Is ARYX or ADC a better dividend investment in 2026?

ARYX currently yields 400000.00% with a 5% 5-year dividend growth rate. ADC yields 4.13% with 5.2% growth. The better choice depends on your goal: ARYX offers higher current income.

What is the dividend yield difference between ARYX and ADC?

ARYX has a forward dividend yield of 400000.00% ($2.00/share annually). ADC yields 4.13% ($3.10/share annually). The yield gap is 399995.87 percentage points.

Home › Compare › ARYX vs ADC

ARYX vs ADC: Dividend Comparison 2026

ARYX yields 400000.00% · ADC yields 4.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARYX wins by $5.011119029548644e+32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARYX

● Live price

400000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.011119029548644e+32M

Annual income

$500,865,583,351,836,840,000,000,000,000,000,000,000.00

Full ARYX calculator →

ADC

Agree Realty Corporation

● Live price

4.13%

Share price

$74.97

Annual div

$3.10

5Y div CAGR

40.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$178.9K

Annual income

$80,797.29

Full ADC calculator →

Portfolio growth — ARYX vs ADC

📍 ARYX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARYX	ADC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARYX + ADC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARYX pays

ADC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARYX

Annual income on $10K today (after 15% tax)

$34,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr

ADC

Annual income on $10K today (after 15% tax)

$351.36/yr

After 10yr DRIP, annual income (after tax)

$68,677.70/yr

At 15% tax rate, ARYX beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARYX + ADC for your $10,000?

ARYX: 50%ADC: 50%

100% ADC50/50100% ARYX

Portfolio after 10yr

$2.505559514774322e+32M

Annual income

$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr

Blended yield

99.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

ARYX

No analyst data

Altman Z

-56.9

Piotroski

1/9

ADC

Analyst Ratings

Strong

Buy

Hold

Consensus: Buy

Price Target

$81.06

+8.1% upside vs current

Range: $75.00 — $84.50

Altman Z

1.6

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARYX buys

ADC buys

No recent congressional trades found for ARYX or ADC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARYXADC

Forward yield	400000.00% ✓	4.13%
Annual dividend / share	$2.00	$3.10 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	40.4% ✓
Portfolio after 10y	$5.011119029548644e+32M	$178.9K ✓
Annual income after 10y	$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓	$80,797.29
Total dividends collected	$5.010957816668433e+32M	$156.7K ✓
Payment frequency	quarterly	monthly
Sector	Stock	REIT

Year-by-year: ARYX vs ADC ($10,000, DRIP)

Year	ARYX Portfolio	ARYX Income/yr	ADC Portfolio	ADC Income/yr	Gap
1← crossover	$40,010,700	$40,000,000.00	$10,990	$580.36	+$40.00M → ARYX
2	$149,615,521,729	$149,572,710,280.37	$12,301	$860.26	+$149615.51M → ARYX
3	$522,880,052,725,200	$522,719,964,116,949.25	$14,104	$1,298.62	+$522880052.71M → ARYX
4	$1,707,862,989,289,045,000	$1,707,303,507,632,628,700.00	$16,691	$2,008.16	+$1707862989289.03M → ARYX
5	$5,213,509,402,845,684,000,000	$5,211,681,989,447,144,000,000.00	$20,580	$3,205.09	+$5213509402845684.00M → ARYX
6	$14,874,219,058,409,543,000,000,000	$14,868,640,603,348,497,000,000,000.00	$26,754	$5,330.02	+$14874219058409543680.00M → ARYX
7	$39,661,196,234,050,755,000,000,000,000	$39,645,280,819,658,260,000,000,000,000.00	$37,196	$9,345.14	+$3.966119623405075e+22M → ARYX
8	$98,838,436,350,327,300,000,000,000,000,000	$98,795,998,870,356,880,000,000,000,000,000.00	$56,244	$17,523.09	+$9.88384363503273e+25M → ARYX
9	$230,205,236,474,344,900,000,000,000,000,000,000	$230,099,479,347,450,050,000,000,000,000,000,000.00	$94,286	$35,736.21	+$2.302052364743449e+29M → ARYX
10	$501,111,902,954,864,400,000,000,000,000,000,000,000	$500,865,583,351,836,840,000,000,000,000,000,000,000.00	$178,949	$80,797.29	+$5.011119029548644e+32M → ARYX

ARYX vs ADC: Complete Analysis 2026

ARYX — Stock

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; and Budiodarone (ATI-2042), an oral antiarrhythmic agent that is in Phase IIb clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat. The company's other clinical development products comprise ATI-7505, an oral prokinetic agent, which is in Phase IIb clinical development for the treatment of chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease; and ATI-9242, an antipsychotic agent in Phase I clinical development for the treatment of schizophrenia and other psychiatric disorders. It also focuses on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal disorders that are in discovery stage. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California.

Full ARYX Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →

📬

Get this ARYX vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARYX vs SCHD ARYX vs JEPI ARYX vs O ARYX vs KO ARYX vs MAIN ARYX vs NNN ARYX vs EPRT ARYX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.